Manage episode 228690748 series 2394758
Here's why Roche's acquisition of gene therapy pioneer Spark Therapeutics and Biogen's acquisition of gene therapy upstart Nightstar Therapeutics could put Regenxbio in play. RHHBY, ONCE, BIIB, NITE, RGNX
Check out more of our content here:
1365 episodes available. A new episode about every day averaging 30 mins duration .